Try our corporate solution for free!
(212) 419-8286

Eli Lilly's total revenue by segment 2015-2019

This graph shows the revenue of Eli Lilly and Company from 2015 to 2019, sorted by segment. Eli Lilly is one of the top global pharmaceutical companies and the world's largest manufacturer and distributor of psychiatric medications. In 2019, the company generated some 4.6 billion U.S. dollars of revenue through its oncology segment.

Revenue of Eli Lilly and Company from 2015 to 2019, by segment

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until November 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2020



Survey time period

2015 to 2019

Supplementary notes

Figures prior to 2017 were taken from previous editions.
* In 2019, "cardiovascular" is included in "other".
** Elanco Animal Health was spun off during 2019.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Eli Lilly"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.